E2F1 and prostate carcinoma: E2f-1 is able to bind with the promoter of the insulin-like growth factor-I receptor (IGF-IR) gene in prostate cancer cells to promote the transcription of IGF-IR, thus enhancing the proliferation of tumor cells [22].